Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment
暂无分享,去创建一个
A. Vossen | K. R. van Straalen | E. Prens | H. H. van der Zee | C. Ardon | A. Rondags | B. Horváth | I. Janse | J. V. van Hasselt
[1] D. Presser,et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity , 2017, The British journal of dermatology.
[2] A. Vossen,et al. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study , 2017, American Journal of Clinical Dermatology.
[3] A. Evers,et al. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross‐sectional study , 2017, The British journal of dermatology.
[4] E. Prens,et al. Pathophysiology of hidradenitis suppurativa: An update. , 2015, Journal of the American Academy of Dermatology.
[5] J. Lapins,et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] A. Alavi,et al. Quality-of-Life Impairment in Patients with Hidradenitis Suppurativa: A Canadian Study , 2015, American Journal of Clinical Dermatology.
[7] G. Jemec,et al. Depression in patients with hidradenitis suppurativa , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[8] G. Jemec. Clinical practice. Hidradenitis suppurativa. , 2012, The New England journal of medicine.
[9] J. Szepietowski,et al. Psychophysical aspects of hidradenitis suppurativa. , 2010, Acta dermato-venereologica.
[10] C. Zouboulis,et al. Comorbidities of hidradenitis suppurativa (acne inversa) , 2010, Dermato-endocrinology.
[11] J. Lapins,et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity , 2009, The British journal of dermatology.
[12] H. Kurzen,et al. What causes hidradenitis suppurativa? , 2008, Experimental dermatology.
[13] G. Jemec,et al. Morbidity in patients with hidradenitis suppurativa , 2001, The British journal of dermatology.
[14] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[15] E. Prens,et al. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group. , 2017, Acta dermato-venereologica.
[16] A. Kimball,et al. The Handicap of Hidradenitis Suppurativa. , 2016, Dermatologic clinics.
[17] A. Alikhan. Hidradenitis Suppurativa. , 2016, JAMA dermatology.